Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. - Wikidata - wikimedia - TriplyDB

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

http://www.wikidata.org/entity/Q38380217

about

Pharmacoepidemiology of testosterone: Curbing off-label prescribing.Body Composition changes with Testosterone Replacement Therapy following Spinal Cord Injury and Aging. A Mini Review.Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women.Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy.Multicenter AIDS Cohort Study Quantitative Coronary Plaque Progression Study: rationale and design.Thyroid function and ischemic heart disease: a Mendelian randomization study.Testosterone treatment in older men: glass half empty or half full?Geriatrics Literature 2016 Year in Review.The role of testosterone in MS risk and course.Association between serum levels of testosterone and biomarkers of subclinical atherosclerosis.The Effect of Testosterone on Cardiovacular Biomarkers in the Testosterone Trials.Sex Differences in Muscle Wasting.Trials of testosterone replacement reporting cardiovascular adverse events.Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab.Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.Conclusions about testosterone therapy and cardiovascular risk.Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Injection Testosterone and Adverse Cardiovascular Events: A Case-crossover Analysis.Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.Why is understanding the relationship of testosterone to cardiovascular risk so important?Serum Androgens and Risk of Atrial Fibrillation in Older Men: The Cardiovascular Health Study.Emerging Evidences in the Long Standing Controversy Regarding Testosterone Replacement Therapy and Cardiovascular Events.What does the research say about androgen use and cerebrovascular events?

P2860

Q38611978-C03DEB16-7512-4081-9003-671DE65A03C9 Q38645004-25AE8415-79B8-48D1-BF5E-AE7A8DAC3C7C Q38816601-50B62BA2-70BD-4A92-8159-82AC0EC13DD3 Q39332432-A0E766C2-DC81-4011-A5E0-0A8A0597026D Q40094777-4ABC342E-AC40-4ABB-A9EA-1A96DFA942BF Q41447468-D7CCF1E8-513E-4AD0-8428-0638C4D710FF Q41486759-CEA722B1-70BA-416D-B0BF-A49011AA47B2 Q46341174-0FA612B4-2AB2-455B-9210-7DDB4DE5370F Q47201174-2201F632-4AF0-4E68-AFA1-64628BEC5D83 Q47257836-DA041F28-939D-468C-8404-E224763101C5 Q47281332-5565E5CB-DD6B-4839-B724-79BE5FC4A7A2 Q47311543-2158CB80-75B0-4EA1-8377-B346D2A0D964 Q47571312-F7DB19D4-FCD4-449E-8602-C9EF8136D341 Q48088703-1DD4D595-18BB-43F7-A611-B8AB8395C679 Q48173359-9144979D-1ADA-406C-9DC4-C643C392930F Q49852771-0332A170-052A-4510-9BEA-4DACF7F2BD68 Q49971559-7C9DCDA0-96DE-4D05-B280-126E17A0EA41 Q49985009-8E097AD9-7A09-4421-9063-6995229D51EA Q50017410-02F13201-8120-4555-95EC-F2B1762B10F9 Q50191659-1A029E80-00F0-4445-B00D-C34F302772BB Q52315820-309EA5C6-6C64-4D0C-B064-1DEBDA106519 Q55261544-524B5F17-DFA2-465D-9A6B-6304DFCDEF7B Q58574549-4734600D-47B7-4BB7-9B5C-ABBFAF84401F

P2860

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

http://www.wikidata.org/entity/Q38380217

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Testosterone Treatment and Cor ...... der Men With Low Testosterone.

@en

type

label

Testosterone Treatment and Cor ...... der Men With Low Testosterone.

@en

prefLabel

Testosterone Treatment and Cor ...... der Men With Low Testosterone.

@en

P1433

Q38380217-C76B2971-5309-4007-8206-19B0F11E01A5

P1476

Q38380217-0FAF35EB-C311-4A4B-9C95-9A0361DD86F8

P2093

Q38380217-02916744-5E05-49C8-849E-7DED0AADA88D

Q38380217-061EFB73-DCBA-464A-AF59-67DFA85A3C14

Q38380217-0AB2D5E1-D7D2-459E-ACC1-10BE389BAE12

Q38380217-0DDFC1F0-1072-4227-BE90-AE86559C7607

Q38380217-2D945D9A-7482-4C37-B711-7BC84EFFD49E

Q38380217-340E0160-8F10-4A12-ADF6-AD65E27C8AC0

Q38380217-34860A8B-BCD2-4493-91E3-F163C8B68E08

Q38380217-40095DF5-831B-4BCB-A5B8-A9F3BBBAF4DD

Q38380217-48705710-2904-4A3C-B9D9-C4D2325B9110

Q38380217-4B402574-31BF-4587-862C-13999C18871F

P2860

Q38380217-0658551F-9497-4D4C-96C9-3B14EF840011

Q38380217-06DE5C58-6BAF-4731-A00A-21017C062BDB

Q38380217-19FF89B0-14B5-4400-A334-A0B393FEAAA5

Q38380217-1A2A4685-F2DC-448E-8D76-F66536B788F5

Q38380217-3188C82B-9D15-49B3-8447-5CDA0B276EF6

Q38380217-37A2137C-5705-4198-8DB3-F6FB89C765C4

Q38380217-39D232DC-961D-41AA-B553-23379B4942CE

Q38380217-3AE6F9F8-B057-4664-A4DC-C7FBBB11B7D9

Q38380217-43DB415C-5C43-4948-9259-DEF9953074D1

Q38380217-4DF45C9C-D0BC-43CE-A630-848F20A132CC

P304

Q38380217-E9539BDE-7C85-47CB-94B2-1B0DC8E49E1D

P31

Q38380217-6FD09DBF-C652-4DA7-A9D9-FF1EB6BA23C0

P356

Q38380217-A4A511E7-775C-42A2-B221-5300DF0522DF

P407

Q38380217-AD876CC6-6D9D-474E-A6FC-76B74E394836

P433

Q38380217-BB221960-F349-4710-A6B7-2201BA5EB820

P478

Q38380217-3E42CBDD-FE6B-427A-9B5B-16513881598B

P50

Q38380217-1AEA7369-BFB3-4F30-90DD-6724D180F096

Q38380217-209CA854-2B57-4458-8C3F-D995E5ADD7FF

Q38380217-2D8D7EBE-6415-43FD-AE27-752F69256262

Q38380217-5100A0FE-B70D-4E71-A60F-CD8E0D329733

Q38380217-62DDA164-23B0-4976-897F-863801749319

Q38380217-66F72694-F6CC-469E-8005-A687381FABA9

P577

Q38380217-1AC886C6-B16C-4CE4-B7EB-5DBDD6AF0E03

P698

Q38380217-775A547A-6944-4D54-85C7-9AE6DD42FDAE

P932

Q38380217-5CED9A37-29C2-4F27-88ED-3B9AD28367B4

P356

JAMA.2016.21043

P1433

Journal of the American Medical Association

P1476

Testosterone Treatment and Cor ...... der Men With Low Testosterone.

@en

P2093

Alisa Stephens-Shields

http://www.w3.org/2001/XMLSchema#string

Alvin M Matsumoto

http://www.w3.org/2001/XMLSchema#string

Denise Cifelli

http://www.w3.org/2001/XMLSchema#string

Emile R Mohler

http://www.w3.org/2001/XMLSchema#string

Glenn R Cunningham

http://www.w3.org/2001/XMLSchema#string

Jill P Crandall

http://www.w3.org/2001/XMLSchema#string

Kristine E Ensrud

http://www.w3.org/2001/XMLSchema#string

Mark E Molitch

http://www.w3.org/2001/XMLSchema#string

Nanette K Wenger

http://www.w3.org/2001/XMLSchema#string

Negin Nezarat

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

Adverse events associated with testosterone administration

The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment

Recruitment and Screening for the Testosterone Trials

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

Effects of Testosterone Treatment in Older Men.

The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosis

Trends in androgen prescribing in the United States, 2001 to 2011.

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

P304

708-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2016.21043

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

317

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Barrett-Connor

Matthew J Budoff

Shalender Bhasin

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28241355

http://www.w3.org/2001/XMLSchema#string

P932

5465430

http://www.w3.org/2001/XMLSchema#string